CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-06 | Lowry Simon C SVP, R&D, CMO | Grant or award | +62,500 | 91,982 | ||
| 2025-03-06 | Lowry Simon C SVP, R&D, CMO | Grant or award · Employee Stock Options (Right to Buy) | +62,500 | 102,999 | ||
| 2025-03-06 | Hartzel William SVP, Bioservices | Grant or award | +62,500 | 109,975 | ||
| 2025-03-06 | Hartzel William SVP, Bioservices | Grant or award · Employee Stock Options (Right to Buy) | +62,500 | 214,711 | ||
| 2025-03-06 | PAPA JOSEPH C President and CEO | Grant or award | +282,500 | 282,500 | ||
| 2025-03-06 | PAPA JOSEPH C President and CEO | Grant or award · Employee Stock Options (Right to Buy) | +282,500 | 1,032,500 | ||
| 2025-03-06 | Glessner Coleen EVP, Quality & Ethics, and CPL | Grant or award | +62,500 | 176,656 | ||
| 2025-03-06 | Glessner Coleen EVP, Quality & Ethics, and CPL | Grant or award · Employee Stock Options (Right to Buy) | +62,500 | 249,613 | ||
| 2025-03-05 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −292 | $5.80 | $2K | 47,183 |
| 2025-03-01 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −313 | $7.48 | $2K | 114,156 |
| 2025-03-01 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −116 | $7.48 | $868 | 23,835 |
| 2025-03-01 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −683 | $7.48 | $5K | 152,337 |
| 2025-02-28 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −382 | $7.48 | $3K | 23,951 |
| 2025-02-28 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −1,073 | $7.48 | $8K | 153,020 |
| 2025-02-12 | Glessner Coleen EVP, Quality & Ethics, and CPL | Returned to the company | −5,913 | 138,547 | ||
| 2025-02-12 | Glessner Coleen EVP, Quality & Ethics, and CPL | Returned to the company | −24,078 | 114,469 | ||
| 2025-02-12 | LINDAHL RICHARD S EVP, Chief Financial Officer | Returned to the company | −16,916 | 154,093 | ||
| 2025-02-09 | Perl Jessica SVP, General Counsel, Corp Sec | Shares withheld for taxes | −918 | $10.00 | $9K | 5,887 |
| 2024-12-15 | Lowry Simon C SVP, R&D, CMO | Grant or award | +29,482 | 29,482 | ||
| 2024-12-15 | Lowry Simon C SVP, R&D, CMO | Grant or award · Employee Stock Option (Right to buy) | +40,499 | 40,499 |
Page 7 of 17 · 330 trades